Refractory adult Coats disease treated with dexamethasone intravitreal implant: A case report

Medicine (Baltimore). 2020 May;99(20):e20249. doi: 10.1097/MD.0000000000020249.

Abstract

Introduction: Coats disease is a sporadic, retinal vascular abnormality, causing blindness. Several interventional methods, including laser photocoagulation, have been proposed; however, the use of intravitreal dexamethasone in refractory Coats disease is not well described.

Patient concerns: A 38-year-old man presented with a painless reduction in visual acuity in his right eye, commencing 15 days prior to initial assessment.

Diagnosis: Clinical manifestations and multimodal imaging indicated Coats disease.

Interventions: Retinal laser photocoagulation was performed in the nonperfused areas, 15 months later, the exudative retinal detachment, and macular edema remained, the patient was then treated with an intravitreal slow-release dexamethasone implant.

Outcomes: The exudative retinal detachment and macular edema had resolved, and the BCVA had also improved.

Conclusion: Dexamethasone intravitreal implantation was effective in treating refractory Coats disease.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Dexamethasone / therapeutic use*
  • Female
  • Glucocorticoids / therapeutic use
  • Humans
  • Intravitreal Injections / methods
  • Male
  • Middle Aged
  • Recurrence
  • Retinal Telangiectasis / drug therapy*
  • Retinal Telangiectasis / physiopathology

Substances

  • Glucocorticoids
  • Dexamethasone